THE HORSHAM CLINIC — History
CCN 394034 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$64M
Latest Revenue (FY2022)
+13.2%
Revenue CAGR (3yr)
2.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $50M | $53M | $64M | +20.1% | +13.2% |
| Operating Expenses | $55M | $61M | $62M | +2.8% | +6.3% |
| Operating Margin | -11.1% | -14.4% | 2.1% | +114.5% | +0.0% |
| Net Income | $-6M | $-8M | $1M | +117.4% | +0.0% |
| Licensed Beds | 206 | 206 | 206 | +0.0% | +0.0% |
| Total Patient Days | 64,518 | 63,825 | 69,406 | +8.7% | +3.7% |
| Medicare Day % | 5% | 5% | 6% | +13.6% | +3.3% |
| Medicaid Day % | 2% | 2% | 1% | -52.2% | -36.1% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.2% ($50M → $64M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+13.2%
This Hospital
+7.6%
State Avg
Latest Margin
2.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $71M | 8.7% |
| FY2024 (proj) | $78M | 15.3% |
| FY2025 (proj) | $85M | 21.9% |